Qanda
Cell & Gene Therapy Consulting · Accelerated by AI
Expert consulting for organizations building cell and gene therapy programs. Deep domain expertise combined with AI to deliver rigorous analysis at unprecedented speed.
Cell & Gene Therapy Consulting · Accelerated by AI
Expert consulting for organizations building cell and gene therapy programs. Deep domain expertise combined with AI to deliver rigorous analysis at unprecedented speed.
What We Do
From initial readiness assessment to first patient treated — we support every stage of your CAR-T or gene therapy program.
Facility gap assessments, GMP compliance review, and implementation roadmaps for point-of-care and centralized CAR-T programs including CliniMACS Prodigy.
IND preparation guidance, clinical development roadmaps, and regulatory strategy for novel CAR-T, TCR-T, and gene-edited cell therapy programs.
SOP development, quality management system design, and CAPA frameworks tailored to your manufacturing platform and regulatory jurisdiction.
Hands-on onsite training, staff capacity building, and implementation support from pre-clinical planning through first patient infusion.
REDCap EDC design, clinical trial data workflows, and informatics strategy built for the complexity of cell therapy operations and long-term follow-up.
Comprehensive literature reviews, competitive landscape analyses, and evidence-based reports with rigorous citations — delivered in days, not weeks.
How We Work
Expert knowledge meets modern AI tooling for faster, more rigorous consulting.
We start with your specific context — platform, team, regulatory environment, and strategic goals.
AI-augmented analysis grounded in real-world cell therapy manufacturing, clinical trials, and regulatory experience.
Actionable, prioritized recommendations — rigorously cited, practically framed, and ready to act on.
Ethics and Independence
Four rules we hold to on every engagement, in writing, before the first invoice.
Every AI service we use runs with model training turned off, and we never reuse one client's confidential information to serve another. We delete our copies of your material when the engagement closes.
Every deliverable is checked line by line by the consultant who signs it. Claims carry citations, and regulatory sources carry the date they were retrieved.
Every engagement is reviewed for conflicts of interest against our clinical and academic commitments before work begins.
An assessment that concludes you should not proceed says exactly that. What we recommend is never a function of what we would like to sell you next.
About Qanda
Qanda was founded by Dr. Stephan Kadauke, physician-scientist and Associate Director of the Cell Based Therapy Laboratory at Children's Hospital of Philadelphia — one of the world's leading CAR-T programs.
With deep operational experience across manufacturing, clinical trials, and health informatics, Qanda brings CHOP-caliber expertise to programs worldwide — from established academic medical centers to emerging programs building their first CAR-T capability.
Get in Touch
Whether you're planning your first CAR-T program or optimizing an existing one, we'd welcome the conversation.
stephan@qanda-ai.com